FDA competition to spur new technology in fighting opioid overdose

The Food and Drug Administration is hosting the 2016 FDA Naloxone App Competition (#naloxoneapp) to encourage computer programmers, public health advocates, clinical researchers, entrepreneurs and...

OCTRI announces 2015 Biomedical Innovation Program award recipients

The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of three research awards through its Biomedical Innovation Program. The program cultivates and...

Orexigen featured in the Portland Business Journal

You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU's office of Technology Transfer & Business Development (TTBD) created a start-up company called...

2014 Oregon Bioscience Conference, Sept. 15-17

The Oregon Bio 2014 Annual Conference highlights exciting trends and opportunities that are emerging in Oregon’s bioscience community. The overarching mission of the Oregon Bioscience Association...

TTBD Innovator Spotlight: Michael P. Hutchens, M.D., M.A.

The office of Technology Transfer & Business Development would like to highlight a particularly innovative or note worthy OHSU innovator and invention at the university. This Fall 2014 quarter,...

OCTRI announces 2014 Biomedical Innovation Program award recipients

The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of four research awards through its Biomedical Innovation Program. The Program cultivates and...

Tech Transfer office internship applications due Aug. 15

OHSU Technology Transfer & Business Development interns provide a valuable service by assisting with technology development and the transition of technology from laboratory to market for the...

Tech Transfer Newsletter: Summer 2014

Check out the latest news in the office of Technology Transfer & Business Development (TTBD) In this issue, we discuss:  OHSU’s partnership with the Allegory Venture Partners – Learn...